Polomar Health Services, Inc. (PMHS) stock
PMHSOTCPharmaceutical PreparationsFiscal year ends December 31
$0.12−0.01 (-4.00%)
Close on Oct 19, 2026Market cap $3.37MP/E –Yield –
Polomar Health Services profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Polomar Health Services's profit margin for the twelve months ending Jun 30, 2026 was -298.3%. For fiscal 2025 it was -1650.8%, against -2280.2% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -1650.8% | +629.4 |
| FY2024 | Dec 31, 2024 | -2280.2% | −875.0 |
| FY2023 | Dec 31, 2023 | -1405.2% | −880.6 |
| FY2022 | Dec 31, 2022 | -524.6% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 13.1% | +11083.7 |
| Q1 FY2026 | Mar 31, 2026 | -2.5% | +10055.9 |
| Q4 FY2025 | Dec 31, 2025 | -1422.2% | +2022.0 |
| Q3 FY2025 | Sep 30, 2025 | -10543.2% | −7788.2 |
| Q2 FY2025 | Jun 30, 2025 | -11070.6% | −9754.7 |
| Q1 FY2025 | Mar 31, 2025 | -10058.5% | −8879.4 |
| Q4 FY2024 | Dec 31, 2024 | -3444.1% | −2706.1 |
| Q3 FY2024 | Sep 30, 2024 | -2754.9% | −1952.6 |
| Q2 FY2024 | Jun 30, 2024 | -1315.9% | −810.2 |
| Q1 FY2024 | Mar 31, 2024 | -1179.0% | −882.1 |
| Q4 FY2023 | Dec 31, 2023 | -738.0% | – |
| Q3 FY2023 | Sep 30, 2023 | -802.4% | – |
| Q4 FY2022 | Dec 31, 2022 | -505.8% | – |
| Q3 FY2022 | Sep 30, 2022 | -297.0% | – |
See a number that looks wrong?